What’s Old is New Again – A review of the current evidence of colchicine in cardiovascular medicine
Publication in refereed journal


Times Cited
Altmetrics Information
.

Other information
AbstractColchicine is a well-established drug approved by the Food and Drug Administration (FDA) for the prevention and treatment of gout. It possesses unique anti-inflammatory properties. Interests in the usage of colchicine in cardiovascular medicine have been rekindled recently with several large trials been carried out to investigate its efficacy in treatment of various cardiac conditions including pericarditis, postpericardiotomy syndrome, atrial fibrillation and coronary artery disease. In this review, the basic pharmacological properties of colchicine will be discussed, and the evidences of its benefits for different applications in cardiovascular medicine will be reviewed.
All Author(s) ListBryan P. Yan, Guang-Ming Tan
Journal nameCurrent Cardiology Reviews
Year2017
Volume Number13
Issue Number2
PublisherBentham Science Publishers
Pages130 - 138
ISSN1573-403X
eISSN1875-6557
LanguagesEnglish-United States

Last updated on 2020-26-03 at 01:56